Screener
Tectonic Therapeutics TECX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (27,301) | (18,298) |
| Other income (expense): | ||
| Interest income | 2,181 | 2,444 |
| Interest expense | (8) | (20) |
| Other expense | (113) | (32) |
| Total other income, net | 2,060 | 2,392 |
| Net loss | (25,241) | (15,906) |
| Other comprehensive loss: |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's interest expense?
- Tectonic Therapeutics (TECX) reported interest expense of $8K in Q1 2026.
- How has Tectonic Therapeutics's interest expense changed year-over-year?
- Tectonic Therapeutics's interest expense decreased by 60.0% year-over-year, from $20K to $8K.
- What is the long-term trend for Tectonic Therapeutics's interest expense?
- Over 2 years (2023 to 2025), Tectonic Therapeutics's interest expense has grown at a -35.6% compound annual growth rate (CAGR), from $152K to $63K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Tectonic Therapeutics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude